The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Recombinant Human Interleukin Market Research Report 2025
Synopsis
Interleukins (ILs) are a group of cytokines (secreted proteins and signal molecules) that were first seen to be expressed by white blood cells (leukocytes). ILs can be divided into four major groups based on distinguishing structural features. However, their amino acid sequence similarity is rather weak (typically 15–25% identity). The human genome encodes more than 50 interleukins and related proteins.
The global Recombinant Human Interleukin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Recombinant Human Interleukin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Human Interleukin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Recombinant Human Interleukin include Qilu Pharmaceutical, Hangzhou Jiuyuan, Merck and Co, Novartis Pharma, Abnova, Advanced Biotechnologies Inc, Cayman Chemical, Cell Signaling Technology and Thermo Fisher, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Interleukin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Interleukin.
Report Scope
The Recombinant Human Interleukin market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Human Interleukin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Interleukin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qilu Pharmaceutical
Hangzhou Jiuyuan
Merck and Co
Novartis Pharma
Abnova
Advanced Biotechnologies Inc
Cayman Chemical
Cell Signaling Technology
Thermo Fisher
Segment by Type
IL-1
IL-2
IL-10
Others
Segment by Application
Medication
Scientific Research
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Interleukin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Interleukin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Interleukins (ILs) are a group of cytokines (secreted proteins and signal molecules) that were first seen to be expressed by white blood cells (leukocytes). ILs can be divided into four major groups based on distinguishing structural features. However, their amino acid sequence similarity is rather weak (typically 15–25% identity). The human genome encodes more than 50 interleukins and related proteins.
The global Recombinant Human Interleukin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Recombinant Human Interleukin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Human Interleukin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Recombinant Human Interleukin include Qilu Pharmaceutical, Hangzhou Jiuyuan, Merck and Co, Novartis Pharma, Abnova, Advanced Biotechnologies Inc, Cayman Chemical, Cell Signaling Technology and Thermo Fisher, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Interleukin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Interleukin.
Report Scope
The Recombinant Human Interleukin market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Human Interleukin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Interleukin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qilu Pharmaceutical
Hangzhou Jiuyuan
Merck and Co
Novartis Pharma
Abnova
Advanced Biotechnologies Inc
Cayman Chemical
Cell Signaling Technology
Thermo Fisher
Segment by Type
IL-1
IL-2
IL-10
Others
Segment by Application
Medication
Scientific Research
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Human Interleukin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Human Interleukin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Recombinant Human Interleukin Market Overview
1.1 Product Overview and Scope of Recombinant Human Interleukin
1.2 Recombinant Human Interleukin Segment by Type
1.2.1 Global Recombinant Human Interleukin Market Value Comparison by Type (2024-2030)
1.2.2 IL-1
1.2.3 IL-2
1.2.4 IL-10
1.2.5 Others
1.3 Recombinant Human Interleukin Segment by Application
1.3.1 Global Recombinant Human Interleukin Market Value by Application: (2024-2030)
1.3.2 Medication
1.3.3 Scientific Research
1.4 Global Recombinant Human Interleukin Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Interleukin Revenue 2019-2030
1.4.2 Global Recombinant Human Interleukin Sales 2019-2030
1.4.3 Global Recombinant Human Interleukin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Human Interleukin Market Competition by Manufacturers
2.1 Global Recombinant Human Interleukin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Human Interleukin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Human Interleukin Average Price by Manufacturers (2019-2024)
2.4 Global Recombinant Human Interleukin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Interleukin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Interleukin, Product Type & Application
2.7 Recombinant Human Interleukin Market Competitive Situation and Trends
2.7.1 Recombinant Human Interleukin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Recombinant Human Interleukin Players Market Share by Revenue
2.7.3 Global Recombinant Human Interleukin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Human Interleukin Retrospective Market Scenario by Region
3.1 Global Recombinant Human Interleukin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Human Interleukin Global Recombinant Human Interleukin Sales by Region: 2019-2030
3.2.1 Global Recombinant Human Interleukin Sales by Region: 2019-2024
3.2.2 Global Recombinant Human Interleukin Sales by Region: 2025-2030
3.3 Global Recombinant Human Interleukin Global Recombinant Human Interleukin Revenue by Region: 2019-2030
3.3.1 Global Recombinant Human Interleukin Revenue by Region: 2019-2024
3.3.2 Global Recombinant Human Interleukin Revenue by Region: 2025-2030
3.4 North America Recombinant Human Interleukin Market Facts & Figures by Country
3.4.1 North America Recombinant Human Interleukin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Human Interleukin Sales by Country (2019-2030)
3.4.3 North America Recombinant Human Interleukin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Recombinant Human Interleukin Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Interleukin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Human Interleukin Sales by Country (2019-2030)
3.5.3 Europe Recombinant Human Interleukin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Interleukin Market Facts & Figures by Country
3.6.1 Asia Pacific Recombinant Human Interleukin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Human Interleukin Sales by Country (2019-2030)
3.6.3 Asia Pacific Recombinant Human Interleukin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Recombinant Human Interleukin Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Interleukin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Human Interleukin Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Human Interleukin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Human Interleukin Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Interleukin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Human Interleukin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Human Interleukin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Recombinant Human Interleukin Sales by Type (2019-2030)
4.1.1 Global Recombinant Human Interleukin Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Interleukin Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Interleukin Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Human Interleukin Revenue by Type (2019-2030)
4.2.1 Global Recombinant Human Interleukin Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Interleukin Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Interleukin Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Human Interleukin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Human Interleukin Sales by Application (2019-2030)
5.1.1 Global Recombinant Human Interleukin Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Interleukin Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Interleukin Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Human Interleukin Revenue by Application (2019-2030)
5.2.1 Global Recombinant Human Interleukin Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Interleukin Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Interleukin Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Human Interleukin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Qilu Pharmaceutical
6.1.1 Qilu Pharmaceutical Corporation Information
6.1.2 Qilu Pharmaceutical Description and Business Overview
6.1.3 Qilu Pharmaceutical Recombinant Human Interleukin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Qilu Pharmaceutical Recombinant Human Interleukin Product Portfolio
6.1.5 Qilu Pharmaceutical Recent Developments/Updates
6.2 Hangzhou Jiuyuan
6.2.1 Hangzhou Jiuyuan Corporation Information
6.2.2 Hangzhou Jiuyuan Description and Business Overview
6.2.3 Hangzhou Jiuyuan Recombinant Human Interleukin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Hangzhou Jiuyuan Recombinant Human Interleukin Product Portfolio
6.2.5 Hangzhou Jiuyuan Recent Developments/Updates
6.3 Merck and Co
6.3.1 Merck and Co Corporation Information
6.3.2 Merck and Co Description and Business Overview
6.3.3 Merck and Co Recombinant Human Interleukin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck and Co Recombinant Human Interleukin Product Portfolio
6.3.5 Merck and Co Recent Developments/Updates
6.4 Novartis Pharma
6.4.1 Novartis Pharma Corporation Information
6.4.2 Novartis Pharma Description and Business Overview
6.4.3 Novartis Pharma Recombinant Human Interleukin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Pharma Recombinant Human Interleukin Product Portfolio
6.4.5 Novartis Pharma Recent Developments/Updates
6.5 Abnova
6.5.1 Abnova Corporation Information
6.5.2 Abnova Description and Business Overview
6.5.3 Abnova Recombinant Human Interleukin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Abnova Recombinant Human Interleukin Product Portfolio
6.5.5 Abnova Recent Developments/Updates
6.6 Advanced Biotechnologies Inc
6.6.1 Advanced Biotechnologies Inc Corporation Information
6.6.2 Advanced Biotechnologies Inc Description and Business Overview
6.6.3 Advanced Biotechnologies Inc Recombinant Human Interleukin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Advanced Biotechnologies Inc Recombinant Human Interleukin Product Portfolio
6.6.5 Advanced Biotechnologies Inc Recent Developments/Updates
6.7 Cayman Chemical
6.6.1 Cayman Chemical Corporation Information
6.6.2 Cayman Chemical Description and Business Overview
6.6.3 Cayman Chemical Recombinant Human Interleukin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cayman Chemical Recombinant Human Interleukin Product Portfolio
6.7.5 Cayman Chemical Recent Developments/Updates
6.8 Cell Signaling Technology
6.8.1 Cell Signaling Technology Corporation Information
6.8.2 Cell Signaling Technology Description and Business Overview
6.8.3 Cell Signaling Technology Recombinant Human Interleukin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cell Signaling Technology Recombinant Human Interleukin Product Portfolio
6.8.5 Cell Signaling Technology Recent Developments/Updates
6.9 Thermo Fisher
6.9.1 Thermo Fisher Corporation Information
6.9.2 Thermo Fisher Description and Business Overview
6.9.3 Thermo Fisher Recombinant Human Interleukin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Thermo Fisher Recombinant Human Interleukin Product Portfolio
6.9.5 Thermo Fisher Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Interleukin Industry Chain Analysis
7.2 Recombinant Human Interleukin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Interleukin Production Mode & Process
7.4 Recombinant Human Interleukin Sales and Marketing
7.4.1 Recombinant Human Interleukin Sales Channels
7.4.2 Recombinant Human Interleukin Distributors
7.5 Recombinant Human Interleukin Customers
8 Recombinant Human Interleukin Market Dynamics
8.1 Recombinant Human Interleukin Industry Trends
8.2 Recombinant Human Interleukin Market Drivers
8.3 Recombinant Human Interleukin Market Challenges
8.4 Recombinant Human Interleukin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Recombinant Human Interleukin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Recombinant Human Interleukin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Recombinant Human Interleukin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Recombinant Human Interleukin Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Recombinant Human Interleukin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Recombinant Human Interleukin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Recombinant Human Interleukin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Recombinant Human Interleukin Average Price (USD/g) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Recombinant Human Interleukin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Recombinant Human Interleukin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Recombinant Human Interleukin, Product Type & Application
Table 12. Global Key Manufacturers of Recombinant Human Interleukin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Recombinant Human Interleukin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Interleukin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Human Interleukin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Recombinant Human Interleukin Sales by Region (2019-2024) & (KG)
Table 18. Global Recombinant Human Interleukin Sales Market Share by Region (2019-2024)
Table 19. Global Recombinant Human Interleukin Sales by Region (2025-2030) & (KG)
Table 20. Global Recombinant Human Interleukin Sales Market Share by Region (2025-2030)
Table 21. Global Recombinant Human Interleukin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Recombinant Human Interleukin Revenue Market Share by Region (2019-2024)
Table 23. Global Recombinant Human Interleukin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Recombinant Human Interleukin Revenue Market Share by Region (2025-2030)
Table 25. North America Recombinant Human Interleukin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Recombinant Human Interleukin Sales by Country (2019-2024) & (KG)
Table 27. North America Recombinant Human Interleukin Sales by Country (2025-2030) & (KG)
Table 28. North America Recombinant Human Interleukin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Recombinant Human Interleukin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Recombinant Human Interleukin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Recombinant Human Interleukin Sales by Country (2019-2024) & (KG)
Table 32. Europe Recombinant Human Interleukin Sales by Country (2025-2030) & (KG)
Table 33. Europe Recombinant Human Interleukin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Recombinant Human Interleukin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Recombinant Human Interleukin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Recombinant Human Interleukin Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Recombinant Human Interleukin Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Recombinant Human Interleukin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Recombinant Human Interleukin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Recombinant Human Interleukin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Recombinant Human Interleukin Sales by Country (2019-2024) & (KG)
Table 42. Latin America Recombinant Human Interleukin Sales by Country (2025-2030) & (KG)
Table 43. Latin America Recombinant Human Interleukin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Recombinant Human Interleukin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Recombinant Human Interleukin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Recombinant Human Interleukin Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Recombinant Human Interleukin Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Recombinant Human Interleukin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Recombinant Human Interleukin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Recombinant Human Interleukin Sales (KG) by Type (2019-2024)
Table 51. Global Recombinant Human Interleukin Sales (KG) by Type (2025-2030)
Table 52. Global Recombinant Human Interleukin Sales Market Share by Type (2019-2024)
Table 53. Global Recombinant Human Interleukin Sales Market Share by Type (2025-2030)
Table 54. Global Recombinant Human Interleukin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Recombinant Human Interleukin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Recombinant Human Interleukin Revenue Market Share by Type (2019-2024)
Table 57. Global Recombinant Human Interleukin Revenue Market Share by Type (2025-2030)
Table 58. Global Recombinant Human Interleukin Price (USD/g) by Type (2019-2024)
Table 59. Global Recombinant Human Interleukin Price (USD/g) by Type (2025-2030)
Table 60. Global Recombinant Human Interleukin Sales (KG) by Application (2019-2024)
Table 61. Global Recombinant Human Interleukin Sales (KG) by Application (2025-2030)
Table 62. Global Recombinant Human Interleukin Sales Market Share by Application (2019-2024)
Table 63. Global Recombinant Human Interleukin Sales Market Share by Application (2025-2030)
Table 64. Global Recombinant Human Interleukin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Recombinant Human Interleukin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Recombinant Human Interleukin Revenue Market Share by Application (2019-2024)
Table 67. Global Recombinant Human Interleukin Revenue Market Share by Application (2025-2030)
Table 68. Global Recombinant Human Interleukin Price (USD/g) by Application (2019-2024)
Table 69. Global Recombinant Human Interleukin Price (USD/g) by Application (2025-2030)
Table 70. Qilu Pharmaceutical Corporation Information
Table 71. Qilu Pharmaceutical Description and Business Overview
Table 72. Qilu Pharmaceutical Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 73. Qilu Pharmaceutical Recombinant Human Interleukin Product
Table 74. Qilu Pharmaceutical Recent Developments/Updates
Table 75. Hangzhou Jiuyuan Corporation Information
Table 76. Hangzhou Jiuyuan Description and Business Overview
Table 77. Hangzhou Jiuyuan Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 78. Hangzhou Jiuyuan Recombinant Human Interleukin Product
Table 79. Hangzhou Jiuyuan Recent Developments/Updates
Table 80. Merck and Co Corporation Information
Table 81. Merck and Co Description and Business Overview
Table 82. Merck and Co Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 83. Merck and Co Recombinant Human Interleukin Product
Table 84. Merck and Co Recent Developments/Updates
Table 85. Novartis Pharma Corporation Information
Table 86. Novartis Pharma Description and Business Overview
Table 87. Novartis Pharma Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 88. Novartis Pharma Recombinant Human Interleukin Product
Table 89. Novartis Pharma Recent Developments/Updates
Table 90. Abnova Corporation Information
Table 91. Abnova Description and Business Overview
Table 92. Abnova Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 93. Abnova Recombinant Human Interleukin Product
Table 94. Abnova Recent Developments/Updates
Table 95. Advanced Biotechnologies Inc Corporation Information
Table 96. Advanced Biotechnologies Inc Description and Business Overview
Table 97. Advanced Biotechnologies Inc Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 98. Advanced Biotechnologies Inc Recombinant Human Interleukin Product
Table 99. Advanced Biotechnologies Inc Recent Developments/Updates
Table 100. Cayman Chemical Corporation Information
Table 101. Cayman Chemical Description and Business Overview
Table 102. Cayman Chemical Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 103. Cayman Chemical Recombinant Human Interleukin Product
Table 104. Cayman Chemical Recent Developments/Updates
Table 105. Cell Signaling Technology Corporation Information
Table 106. Cell Signaling Technology Description and Business Overview
Table 107. Cell Signaling Technology Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 108. Cell Signaling Technology Recombinant Human Interleukin Product
Table 109. Cell Signaling Technology Recent Developments/Updates
Table 110. Thermo Fisher Corporation Information
Table 111. Thermo Fisher Description and Business Overview
Table 112. Thermo Fisher Recombinant Human Interleukin Sales (KG), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 113. Thermo Fisher Recombinant Human Interleukin Product
Table 114. Thermo Fisher Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Recombinant Human Interleukin Distributors List
Table 118. Recombinant Human Interleukin Customers List
Table 119. Recombinant Human Interleukin Market Trends
Table 120. Recombinant Human Interleukin Market Drivers
Table 121. Recombinant Human Interleukin Market Challenges
Table 122. Recombinant Human Interleukin Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Recombinant Human Interleukin
Figure 2. Global Recombinant Human Interleukin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Recombinant Human Interleukin Market Share by Type in 2023 & 2030
Figure 4. IL-1 Product Picture
Figure 5. IL-2 Product Picture
Figure 6. IL-10 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Recombinant Human Interleukin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Recombinant Human Interleukin Market Share by Application in 2023 & 2030
Figure 10. Medication
Figure 11. Scientific Research
Figure 12. Global Recombinant Human Interleukin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Recombinant Human Interleukin Market Size (2019-2030) & (US$ Million)
Figure 14. Global Recombinant Human Interleukin Sales (2019-2030) & (KG)
Figure 15. Global Recombinant Human Interleukin Average Price (USD/g) & (2019-2030)
Figure 16. Recombinant Human Interleukin Report Years Considered
Figure 17. Recombinant Human Interleukin Sales Share by Manufacturers in 2023
Figure 18. Global Recombinant Human Interleukin Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Recombinant Human Interleukin Players: Market Share by Revenue in 2023
Figure 20. Recombinant Human Interleukin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Recombinant Human Interleukin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Recombinant Human Interleukin Sales Market Share by Country (2019-2030)
Figure 23. North America Recombinant Human Interleukin Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Recombinant Human Interleukin Sales Market Share by Country (2019-2030)
Figure 27. Europe Recombinant Human Interleukin Revenue Market Share by Country (2019-2030)
Figure 28. Germany Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Recombinant Human Interleukin Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Recombinant Human Interleukin Revenue Market Share by Region (2019-2030)
Figure 35. China Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Recombinant Human Interleukin Sales Market Share by Country (2019-2030)
Figure 46. Latin America Recombinant Human Interleukin Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Recombinant Human Interleukin Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Recombinant Human Interleukin Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Recombinant Human Interleukin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Recombinant Human Interleukin by Type (2019-2030)
Figure 56. Global Revenue Market Share of Recombinant Human Interleukin by Type (2019-2030)
Figure 57. Global Recombinant Human Interleukin Price (USD/g) by Type (2019-2030)
Figure 58. Global Sales Market Share of Recombinant Human Interleukin by Application (2019-2030)
Figure 59. Global Revenue Market Share of Recombinant Human Interleukin by Application (2019-2030)
Figure 60. Global Recombinant Human Interleukin Price (USD/g) by Application (2019-2030)
Figure 61. Recombinant Human Interleukin Value Chain
Figure 62. Recombinant Human Interleukin Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
